Discussion in 'Insulin Pumps' started by Ellen, Sep 25, 2013.
Very interesting. What did they copy I wonder?
Too bad they didn't copy the IOB calculator formula while they were at it!
oh im sure mdt would have a fit if that happened.
Isn't this what they did with Deltec? I think it's the same stuff, too. Bolus calculations, etc.
Does anyone know do patents eventually expire? It would nice to see what would happen to the pump market if other pump companies were free of Medtronic patents.
The lawsuit says Insulet copied 2 patents, which basically comes down to the devices' remote programming (Pod's PDM that does similar tasks as the MedT remote). Despite the complete differences in devices, Medtronic is basically saying "only we can do what you would expect pumps to do so no one else can do that."
It's somewhat more complicated than this, but you can assume that the patents expire 17 years from their issue date or 20 years from their application date, whichever time period is longer.
I'll bet this is the patent referred on this case (External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities). Valid till 2019
Separate names with a comma.